nav open
¸Þ´º
nav open
ȸ»ç¼Ò°³
Àλ縻(±¹¹®)
Àλ縻(About Us)
¿À½Ã´Â ±æ
»ç¾÷¼Ò°³
»ç¾÷¼Ò°³1
»ç¾÷¼Ò°³2
»ç¾÷ºÐ¾ß
»ç¾÷ºÐ¾ß1
»ç¾÷ºÐ¾ß2
»ç¾÷ºÐ¾ß3
¿Â¶óÀι®ÀÇ
¿Â¶óÀι®ÀÇ(Contact)
Ä¿¹Â´ÏƼ
ÀÚ·á½Ç
nav open
ȸ»ç¼Ò°³
Àλ縻(±¹¹®)
Àλ縻(About Us)
¿À½Ã´Â ±æ
»ç¾÷¼Ò°³
»ç¾÷¼Ò°³1
»ç¾÷¼Ò°³2
»ç¾÷ºÐ¾ß
»ç¾÷ºÐ¾ß1
»ç¾÷ºÐ¾ß2
»ç¾÷ºÐ¾ß3
¿Â¶óÀι®ÀÇ
¿Â¶óÀι®ÀÇ(Contact)
Ä¿¹Â´ÏƼ
ÀÚ·á½Ç
Ä¿¹Â´ÏƼ
¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.
Ä¿¹Â´ÏƼ
ÀÚ·á½Ç
Ȩ
Ä¿¹Â´ÏƼ
ÀÚ·á½Ç
ÀÚ·á½Ç
Á¦¸ñ
EU Regulatory MDD ¿¡¼ MDR, IVDR Àüȯ¿¡ µû¸¥ Clinical trialÀ» Æ÷ÇÔÇÑ Áö¿ø¹× Áغñ°ü·Ã
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
ÀÛ¼ºÀÏÀÚ
2023-03-27
Á¶È¸¼ö
98
ÇöÀç»óÅ MDDµîÀº EUÀÇ MDR2017/745, IVDR2017/746À¸·Î Regulatory requirement Á¶°ÇÀÌ º¯ÇÏ°Ô
µÇ¾ú½À´Ï´Ù.
ÀÇ·á±âmedical device,
Áø´ÜÀÇ·á±â In Vitro Diagnostic Medical device Regulation ÁøÇà½Ã¿¡´Â
clinical ÀÓ»ó½ÃÇè,documentation, reporting, CE certification µî Á¶°Çº¯È¿¡ ¸Â°Ô ÁøÇàÇϼžßÇÕ´Ï´Ù.
ÀúÈñ¿¡ °è¾àµÈ Æò±ÕÀûÀÎ regulatory submission timeÀº 3ÁÖ¸é °¡´ÉÇÏ°í,
CE Marking , re-certification of CE Marking Àº clinical investigationÀ» ¿ä±¸ÇÕ´Ï´Ù.
clinical trialÀÓ»ó½ÃÇè¿¡ ´ëÇÑ ºÎ´ã°ú ºñ¿ëºÎ´ãµî¿¡ ´ëÇØ ºñ¿ëÀ» Àý°¨ÇÏ°í , Àü·«ÀûÀÌ°í ½ÇÁ¦ÀûÀÎ Á¢±ÙÀ¸·Î
½ÇÆÐÀ§Çè¿¡´ëÇÑ Á¶»ç,µðÀÚÀÎ, Á¢±Ù ,°èȹÀ» Á¦°øÇÕ´Ï´Ù.
ÁøÇà°úÁ¤: Verification of Qualification & Classification--Analysis of Harmonized Standards--Risk Management and Analysis--
Clinical Evaluation--Preparation and Verification of the technical documentation--CE Marking--Product Registraion--
--POST Market Surveillance & Vigilance Á¦Ç°µî·Ï, Ãâ½ÃÈıîÁöÀÇ clinical follow-up investigation.
EUROPEÁøÃâ½Ã¿¡ ¸¹Àº ÀÌ¿ë ºÎŹµå¸³´Ï´Ù.
÷ºÎÆÄÀÏ